0001644793-18-000001.txt : 20180629
0001644793-18-000001.hdr.sgml : 20180629
20180628173417
ACCESSION NUMBER: 0001644793-18-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180629
DATE AS OF CHANGE: 20180628
EFFECTIVENESS DATE: 20180629
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TAI Diagnostics, Inc.
CENTRAL INDEX KEY: 0001644793
IRS NUMBER: 454742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-297057
FILM NUMBER: 18926514
BUSINESS ADDRESS:
STREET 1: 1225 DISCOVERY PARKWAY
CITY: WAUWATOSA
STATE: WI
ZIP: 53226
BUSINESS PHONE: 262-501-6264
MAIL ADDRESS:
STREET 1: 1225 DISCOVERY PARKWAY
CITY: WAUWATOSA
STATE: WI
ZIP: 53226
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001644793
TAI Diagnostics, Inc.
10101 Innovation Drive
Suite 700
WAUWATOSA
WI
WISCONSIN
53226
414-800-1025
DELAWARE
None
None
Corporation
true
2015
FRANK
LANGLEY
10101 INNOVATION DRIVE
SUITE 600
WAUWATOSA
WI
WISCONSIN
53226
Executive Officer
Director
MICHAEL
E.
MITCHELL
10101 INNOVATION DRIVE
SUITE 600
WAUWATOSA
WI
WISCONSIN
53226
Executive Officer
Director
AOY
TOMITA
MITCHELL
10101 INNOVATION DRIVE
SUITE 600
WAUWATOSA
WI
WISCONSIN
53226
Executive Officer
Director
JOHN
FOWLER
10101 INNOVATION DRIVE
SUITE 600
WAUWATOSA
WI
WISCONSIN
53226
Director
JOHN
NEIS
10101 INNOVATION DRIVE
SUITE 600
WAUWATOSA
WI
WISCONSIN
53226
Director
Biotechnology
Decline to Disclose
- 06b
true
0001644793-17-000001
2017-10-10
false
true
true
false
0
13000000
12830000
170000
false
34
0
0
0
true
Proceeds will be used for product development and other general corporate purposes. The executive officers will receive compensation from the Issuer's revenues and investment proceeds.
false
TAI Diagnostics, Inc.
Frank Langley
Frank Langley
Chief Executive Officer
2018-06-28